| Wilkin, Timothy J |
Weill Medical Coll Of Cornell Univ
United States |
Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub) |
5UG1CA275414-02 |
|
Silvina Frech, Ph.D., M.S. |
| Varmus, Harold E. |
Weill Medical Coll Of Cornell Univ
United States |
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells |
5U01CA224326-05 |
|
Eva Szabo, M.D. |
| Vilar-Sanchez, Eduardo |
University Of Tx Md Anderson Can Ctr
United States |
Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome |
5R01CA260761-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Asad Umar, D.V.M., Ph.D. |
| Furuta, Saori |
Case Western Reserve University
United States |
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer |
5R01CA248304-05 |
|
|
| Lin, Jia-Ren |
Harvard Medical School
United States |
Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images |
5R50CA274277-02 |
|
Richard Mazurchuk, Ph.D. |
| Chen, Grace Y. |
University Of Michigan At Ann Arbor
United States |
Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention |
5R21CA273646-02 |
|
Winfred Malone, Ph.D., M.P.H. |
| Goggins, Michael G. |
Johns Hopkins University
United States |
Using markers to improve pancreatic cancer screening and surveillance: a multi-center study |
5U01CA210170-07 |
PAR-21-334 (U01 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
|
Rachel Altshuler, Ph.D. |
| Cheville, Andrea Lynne |
Mayo Clinic Rochester
United States |
Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial |
4R33CA278594-02 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
|
Rachel Altshuler, Ph.D. |